https://doi.org/10.4081/hmr.v1i7.628

First-line therapy of chronic lymphocytic leukemia: when and how to treat

Vol. 1 No. 7: Chronic Lymphocytic Leukemia: Achievements and Controversies
Published: June 16, 2009
Abstract Views: 188
PDF: 248
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Ester M. Orlandi
support@pagepress.org
Chronic lymphocytic leukemia (CLL) shows a remarkable clinical heterogeneity: there are some patients with smouldering disease who may not have an altered survival due to CLL, and patients who will certainly have shorter expected survival owing to their progressive disease. In the last decade, impressive progress has been achieved in biological characterization of CLL, allowing better understanding of the pathophysiology of the disease and identification of biological features relevant to prognostic stratification. In the same time period, new therapeutic options, including auto and allotransplantation procedures, monoclonal antibodies (Mab) and new drugs have become available, in addition to alkylating agents and purine analogs.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Orlandi, E. M. (2009). First-line therapy of chronic lymphocytic leukemia: when and how to treat. Hematology Meeting Reports (formerly Haematologica Reports), 1(7). https://doi.org/10.4081/hmr.v1i7.628
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).